U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415252) titled 'SkyVaricella(R) (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years' on Jan. 27.
Brief Summary: The goal of this study is to evaluate the safety and immunogenicity of an investigational varicella vaccine in children. Researchers will compare the investigational vaccine, NBP608, with licensed varicella vaccines. The study includes children aged 12 months to 12 years.
Approximately 780 participants will take part in this study. Participants will be randomly assigned to receive either the investigational vaccine (NBP608) or licensed varicella vaccines. Some participants will receive two doses, while ot...